Antigen tests are very specific for the virus but are not as sensitive as molecular tests. Antigen tests detect proteins from the virus. Molecular tests (also known as PCR tests) detect genetic material from the virus. There are different kinds of tests for COVID-19. Purchase the INDICAID QUALITY CONTROLS (100 PACKS) VIA SALES PRO Purchase 100 BOXES OR LESS (5+/5-)- PURCHASE ONLINE Purchase These Important Quality Controls View / Download The INDICAID Quick Reference Guide The Quality Controls Quick Reference Guide Quality control requirements should be followed in conformance with local, state, and federal regulations or accreditation requirements and the user laboratory’s standard quality control procedures. It is the responsibility of each laboratory or healthcare setting using the INDICAID COVID-19 Rapid Antigen Test to establish an adequate quality assurance program to ensure the performance of the test kit under its specific locations and conditions of use. The Quality Controls consist of positive and negative control samples that should be run once with every new lot, shipment, and each new user, using the test procedure provided. The controls are specifically formulated and manufactured to ensure that the test’s reagents and materials are working and that the test procedure is correctly performed. The INDICAID COVID-19 Antigen Quality Controls are external liquid quality controls. This product has not been FDA cleared or approved. The INDICAID COVID-19 Rapid Antigen Test is only for in vitro diagnostic use under the Food and Drug Administration’s Emergency Use Authorization. Anterior nasal swab specimens may be collected by an HCP or self-collected by individuals 18 years of age or older, under the supervision of an HCP. For individuals without symptoms or other epidemiological reasons to suspect COVID-19, it is authorized when tested at least three times over five days with at least 48 hours between tests. The test is performed by a CLIA Certified Health Care Provider (HCP) using direct anterior nasal swab specimens from suspected COVID-19 individuals within the first five (5) days of symptom onset when tested at least twice over three days with at least 48 hours between tests.

The INDICAID COVID-19 Rapid Antigen Test is a rapid lateral flow immunoassay device intended for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2. The INDICAID COVID-19 Rapid Antigen Test detects antigens from SARS-CoV-2 virus and can be used for COVID-19 screening during active infection. Sensitivity 88.9% Specificity 96.8% Overall accuracy 95.6% Avoid direct sunlight.ġ5 Months (With 3 Month FDA Extension - Learn More)

Rapid covid testing accuracy